Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Double-Blind, 3-Way Parallel Study to Compare the Pharmacokinetics, Safety and Tolerability of BMO-2 to EU and US Sourced Humira® Administered as a Single Dose (40 mg) Subcutaneous Injection in Healthy Adults.
Epistemonikos ID: 9894254cef3c5aafc32b45a0dc4c72013e9c3df2
First added on: May 12, 2024